Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross L Levine

Showing results (1-10 of 422) with videos related to

Pageof 43
Sort By:
Current Topics in Microbiology and Immunology|August 9, 2011
JAK-mutant myeloproliferative neoplasmsRoss L Levine
Seminars in Oncology|April 28, 2009
Janus kinase mutationsRoss L Levine
Leukemia & Lymphoma|January 29, 2013
Vascular endothelial growth factor expression in acute myeloid leukemia: a biomarker ready for primetime?Ross L Levine
The New England Journal of Medicine|December 12, 2013
Another piece of the myeloproliferative neoplasms puzzleRoss L Levine
Hematology/Oncology Clinics of North America|September 27, 2012
Non-CML myeloproliferative diseases. PrefaceRoss L Levine
Best Practice & Research. Clinical Haematology|December 5, 2009
Mechanisms of mutations in myeloproliferative neoplasmsRoss L Levine
Science Advances|September 12, 2020
Cancer did not stay home for COVID-19Ross L Levine
Best Practice & Research. Clinical Haematology|December 7, 2013
Molecular pathogenesis of AML: translating insights to the clinicRoss L Levine
Blood|April 25, 2008
JAK2V617F: you can't have too muchRoss L Levine
Nature Genetics|August 28, 2009
Inherited susceptibility to pediatric acute lymphoblastic leukemiaRoss L Levine
Pageof 43

Showing results (1-10 of 422) with videos related to

Sort By:
Pageof 43
Current Topics in Microbiology and Immunology|August 9, 2011
JAK-mutant myeloproliferative neoplasmsRoss L Levine
Seminars in Oncology|April 28, 2009
Janus kinase mutationsRoss L Levine
Leukemia & Lymphoma|January 29, 2013
Vascular endothelial growth factor expression in acute myeloid leukemia: a biomarker ready for primetime?Ross L Levine
The New England Journal of Medicine|December 12, 2013
Another piece of the myeloproliferative neoplasms puzzleRoss L Levine
Hematology/Oncology Clinics of North America|September 27, 2012
Non-CML myeloproliferative diseases. PrefaceRoss L Levine
Best Practice & Research. Clinical Haematology|December 5, 2009
Mechanisms of mutations in myeloproliferative neoplasmsRoss L Levine
Science Advances|September 12, 2020
Cancer did not stay home for COVID-19Ross L Levine
Best Practice & Research. Clinical Haematology|December 7, 2013
Molecular pathogenesis of AML: translating insights to the clinicRoss L Levine
Blood|April 25, 2008
JAK2V617F: you can't have too muchRoss L Levine
Nature Genetics|August 28, 2009
Inherited susceptibility to pediatric acute lymphoblastic leukemiaRoss L Levine
Pageof 43